Label: PREMIER VALUE CHEST CONGESTION RELIEF- guaifenesin tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated October 9, 2015

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredient - (per tablet)

    Guaifenesin  400mg  Expectorant.

  • PURPOSE

    Guaifenesin ;                    Expectorant

  • INDICATIONS & USAGE

    helps loosen phlegm (mucus) and thin
    bronchial secretions to rid the bronchial passageways of bothersome mucus
    • helps make coughs more productive

  • WARNINGS

    Ask doctor before use if you have

    persistent or chronic cough, such as occurs with smoking, asthma, bronchitis or emphysema

    cough is accompanied by excessive phlegm (mucous)

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children

    In case of overdose,get medical help or contact a poison control

    cenetr immediately.

  • STOP USE

    Stop use and ask doctor if

    Symptoms are accompanied by fever, rash or persistent headache

    cough persists for more than 1 week or tends to recur

    A persistent cough may be a sign of a serious condition

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breastfeeding, ask a health professional before use

  • DOSAGE & ADMINISTRATION

    Directions         
    • Adults and children 12 years of age and over:     
    take 1 tablet every 4 hours as needed     
    • Children 6 to 10 under 12 years of age: take 1/2 tablet every 4 hours as needed
    • Children under 6 years of age: consult a doctor     
    Do not exceed 6 doses in a 24 hour period or as directed by a doctor

  • INACTIVE INGREDIENT

    magnesium stearate,microcrystalline cellulose.May also contain ; colloidal ; silicon dioxide, ; co ; povidone ,dicalcium phosphate maltodextrin,sodium starch glycolate,stearic acid.

  • PRINCIPAL DISPLAY PANEL

    image of carton

  • INGREDIENTS AND APPEARANCE
    PREMIER VALUE CHEST CONGESTION RELIEF 
    guaifenesin tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-019
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ) Guaifenesin400 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    COPOVIDONE (UNII: D9C330MD8B)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeOVALSize17mm
    FlavorImprint Code PH063
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68016-019-011 in 1 CARTON
    150 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34105/04/2009
    Labeler - Chain Drug Consortium, LLC (101668460)
    Registrant - Reese Pharmaceutical Co (004172052)
    Establishment
    NameAddressID/FEIBusiness Operations
    Reese Pharmaceutical Co004172052relabel(68016-019) , repack(68016-019)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!